451 related articles for article (PubMed ID: 24011475)
1. A study of the effectiveness of a needle-free injection device compared with a needle and syringe used to vaccinate calves against bovine viral diarrhea and infectious bovine rhinotracheitis viruses.
Rey MR; Undi M; Rodriguez-Lecompte JC; Joseph T; Morrison J; Yitbarek A; Wittenberg K; Tremblay R; Crow GH; Ominski KH
Vet J; 2013 Oct; 198(1):235-8. PubMed ID: 24011475
[TBL] [Abstract][Full Text] [Related]
2. Effects of gastrointestinal parasites on parasite burden, rectal temperature, and antibody titer responses to vaccination and infectious bovine rhinotracheitis virus challenge.
Schutz JS; Carroll JA; Gasbarre LC; Shelton TA; Nordstrom ST; Hutcheson JP; Van Campen H; Engle TE
J Anim Sci; 2012 Jun; 90(6):1948-54. PubMed ID: 22648753
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
[TBL] [Abstract][Full Text] [Related]
4. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
[TBL] [Abstract][Full Text] [Related]
5. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of viral components of a nonabortigenic combination vaccine for prevention of respiratory and reproductive system diseases in cattle.
Talens LT; Beckenhauer WH; Thurber ET; Cooley AJ; Schultz RD
J Am Vet Med Assoc; 1989 May; 194(9):1273-80. PubMed ID: 2542202
[TBL] [Abstract][Full Text] [Related]
7. Associations between health and productivity in cow-calf beef herds and persistent infection with bovine viral diarrhea virus, antibodies against bovine viral diarrhea virus, or antibodies against infectious bovine rhinotracheitis virus in calves.
Waldner CL; Kennedy RI
Am J Vet Res; 2008 Jul; 69(7):916-27. PubMed ID: 18593246
[TBL] [Abstract][Full Text] [Related]
8. Comparative serological response in calves to eight commercial vaccines against infectious bovine rhinotracheitis, parainfluenza-3, bovine respiratory syncytial, and bovine viral diarrhea viruses.
Van Donkersgoed J; van den Hurk JV; McCartney D; Harland RJ
Can Vet J; 1991 Dec; 32(12):727-33. PubMed ID: 17423913
[TBL] [Abstract][Full Text] [Related]
9. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
[TBL] [Abstract][Full Text] [Related]
11. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
[TBL] [Abstract][Full Text] [Related]
12. Serological responses in calves to vaccines against bovine respiratory syncytial, infectious bovine rhinotracheitis, bovine viral diarrhoea and parainfluenza-3 viruses.
Tollis M; Di Trani L; Cordioli P; Vignolo E; Di Pasquale I
Dev Biol Stand; 1996; 86():147-56. PubMed ID: 8785944
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
[TBL] [Abstract][Full Text] [Related]
14. Virus detection by PCR following vaccination of naive calves with intranasal or injectable multivalent modified-live viral vaccines.
Walz PH; Newcomer BW; Riddell KP; Scruggs DW; Cortese VS
J Vet Diagn Invest; 2017 Sep; 29(5):628-635. PubMed ID: 28545321
[TBL] [Abstract][Full Text] [Related]
15. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
[TBL] [Abstract][Full Text] [Related]
16. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves.
Fulton RW; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Payton ME; Duff GC; Step DL; Walker DA
Can J Vet Res; 2005 Jul; 69(3):161-9. PubMed ID: 16187545
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of circulating bovine viral diarrhea virus type 2 maternal antibody level and response to vaccination in Angus calves.
Downey ED; Tait RG; Mayes MS; Park CA; Ridpath JF; Garrick DJ; Reecy JM
J Anim Sci; 2013 Sep; 91(9):4440-50. PubMed ID: 23881675
[TBL] [Abstract][Full Text] [Related]
18. Clinical and microbiological effects in high-risk beef calves administered intranasal or parenteral modified-live virus vaccines.
Powledge SA; McAtee TB; Woolums AR; Robin Falkner T; Groves JT; Thoresen M; Valeris-Chacin R; Richeson JT
J Anim Sci; 2022 Nov; 100(11):. PubMed ID: 35926833
[TBL] [Abstract][Full Text] [Related]
19. Anti-bovine herpesvirus and anti-bovine viral diarrhea virus antibody responses in pregnant Holstein dairy cattle following administration of a multivalent killed virus vaccine.
Smith BI; Rieger RH; Dickens CM; Schultz RD; Aceto H
Am J Vet Res; 2015 Oct; 76(10):913-20. PubMed ID: 26413830
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of shedding of bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 after vaccination of calves with a multivalent modified-live virus vaccine.
Kleiboeker SB; Lee SM; Jones CA; Estes DM
J Am Vet Med Assoc; 2003 May; 222(10):1399-403. PubMed ID: 12762386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
